Earnings Call · Q1 FY2026·2026-05-04

Q1 26EPS -16.48%·Rev n/aQ4 25EPS -43.45%·Rev n/aQ3 25EPS -64.71%·Rev n/aQ2 25EPS +39.81%·Rev n/a⚠ consensus missing

BIOMARIN PHARMACEUTICAL INC BMRN

Traci McCarty

Alexander Hardy — Chief Executive Officer

Brian Mueller — EVP, Chief Financial Officer

Cristin Hubbard — EVP, Chief Commercial Officer

Gregory Friberg — EVP, Chief R&D Officer

−4.0%1d on move date−4.8% vs SPY3d−2.4%5d−5.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BMRN calls or request research access.

More BMRN calls Browse calls Request research access